C-Line

C-Line is a Swiss biotechnology company specializing in advanced cell line development (CLD) technologies for the biopharmaceutical industry. Founded by the former leadership team of Selexis, the company provides high-performance mammalian cell line engineering services designed to optimize the production of complex biologics, including multispecific antibodies and difficult-to-express proteins. C-Line leverages proprietary genetic elements and expression vectors to generate stable, high-yielding clones, significantly accelerating the transition from discovery to clinical manufacturing. The company's expertise spans vector construction, transfection, and automated clone selection, offering tailored solutions to pharmaceutical and biotech partners worldwide.